Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups

BACKGROUND: In HIV clinical trials, proportions of Black and female participants achieving virologic suppression (VS) are often lower compared with White and male participants. As the antiretroviral therapy (ART) landscape continues to evolve, addressing existing challenges in clinical trial diversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawlings, M Keith, Letang, Emilio, Quercia, Romina, Grove, Richard, DeMasi, Ralph, Min, Sherene, Vannappagari, Vani, Zolopa, Andrew, van Wyk, Jean, Smith, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423381/
https://www.ncbi.nlm.nih.gov/pubmed/36046700
http://dx.doi.org/10.1093/ofid/ofac304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423381/
https://www.ncbi.nlm.nih.gov/pubmed/36046700
http://dx.doi.org/10.1093/ofid/ofac304

Ejemplares similares